Evidence map›Paper›PMID 32557395›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2020

100% peer review in radiation oncology: is it feasible?

E Martin-Garcia, F Celada-Álvarez, M J Pérez-Calatayud, M Rodriguez-Pla, O Prato-Carreño, D Farga-Albiol, O Pons-Llanas, S Roldán-Ortega, E Collado-Ballesteros, F J Martinez-Arcelus and 10 more

Abstract read
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Large language model-augmented learning for auto-delineation of treatment targets in head-and-neck cancer radiotherapy.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

E Martin-GarciaRadiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain. martin_eligar@gva.es.ORCID http://orcid.org/0000-0002-3411-5071
F Celada-ÁlvarezRadiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
M J Pérez-CalatayudRadiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
M Rodriguez-PlaRadiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
O Prato-CarreñoRadiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
D Farga-AlbiolRadiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
O Pons-LlanasRadiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
S Roldán-OrtegaRadiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
E Collado-BallesterosRadiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
F J Martinez-ArcelusRadiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
Y Bernisz-DiazRadiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
V A MaciasRadiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
J ChimenoPhysics Section, Radiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
J Gimeno-OlmosPhysics Section, Radiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
F LlisoPhysics Section, Radiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
V CarmonaPhysics Section, Radiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
J C RuizPhysics Section, Radiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
J Pérez-CalatayudPhysics Section, Radiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
A Tormo-MicóRadiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.
A J Conde-MorenoRadiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePeer review has been proposed as a strategy to ensure patient safety and plan quality in radiation oncology. Despite its potential benefits, barriers commonly exist to its optimal implementation in daily clinical routine. Our purpose is to analyze peer-review process at our institution. METHODS AND MATERIALS: Based on our group peer-review process, we quantified the rate of plan changes, time and resources needed for this process. Prospectively, data on cases presented at our institutional peer-review conference attended by physicians, resident physicians and physicists were collected. Items such as time to present per case, type of patient (adult or pediatric), treatment intent, dose, aimed technique, disease location and receipt of previous radiation were gathered. Cases were then analyzed to determine the rate of major change, minor change and plan rejection after presentation as well as the median time per session.

resultsOver a period of 4 weeks, 148 cases were reviewed. Median of attendants was six physicians, three in-training-physicians and one physicist. Median time per session was 38 (4-72) minutes. 59.5% of cases presented in 1-4 min, 32.4% in 5-9 min and 8.1% in ≥ 10 min. 79.1% of cases were accepted without changes, 11.5% with minor changes, 6% with major changes and 3.4% were rejected with indication of new presentation. Most frequent reason of change was contouring corrections (53.8%) followed by dose or fractionation (26.9%).

conclusionEveryday group consensus peer review is an efficient manner to recollect clinical and technical data of cases presented to ensure quality radiation care before initiation of treatment as well as ensuring department quality in a feedback team environment. This model is feasible within the normal operation of every radiation oncology Department.

Indexed as

Age FactorsConsensusConsensus Statements as TopicFeasibility StudiesHumansNeoplasmsOrgans at RiskPeer Review, Health CareRadiation OncologyTime FactorsPatient safetyPeer reviewQuality assuranceRadiation oncologyTreatment planningTreatment quality

Identifiers

PMID32557395
PMCPMC7299249

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.